Evidence map›Paper›PMID 41841732›Full record

ArticleMicrobiology spectrum2026

Targeting MCR-3 and membrane biosynthesis: mechanistic insights into pterostilbene-colistin synergy.

Fei Zeng, Wenjuan Yin, Huilian Duan, Shuxin He, Luying Sun, Jie Zhang, Siming Wang, Feng Liu, Yuangong Zhang

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fei ZengKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Wenjuan YinKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.ORCID 0009-0009-9695-8224
Huilian DuanKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Shuxin HeKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Luying SunKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Jie ZhangKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Siming WangKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.
Feng LiuKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.ORCID 0000-0001-9815-4187
Yuangong ZhangKey Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University, Baoding, China.ORCID 0000-0001-5264-560X

Funding

National Natural Science Foundation of China 82471463Natural Science Foundation of Hebei Province H2024201044The Central Guidance on Local Science and Technology Development Fund of Hebei Province 226Z2604GThe Medical Scientific Research of Hebei Health Commission 20231560
6 · The paper itself

Abstract

Colistin is a crucial antibiotic for treating infections caused by multidrug-resistant Enterobacterales. However, the emergence of plasmid-mediated

Indexed as

Anti-Bacterial AgentsColistinEscherichia coliEscherichia coli ProteinsStilbenesAnimalsCell MembraneDrug SynergismEscherichia coli InfectionsEthanolaminephosphotransferaseMicrobial Sensitivity TestsMolecular Docking SimulationTransferases (Other Substituted Phosphate Groups)Anti-Bacterial AgentsColistinEscherichia coli ProteinsEthanolaminephosphotransferaseMCR-3 protein, E colipterostilbeneStilbenesTransferases (Other Substituted Phosphate Groups)antibiotic adjuvantcolistinMCR-3membrane disruptionpterostilbene

Identifiers

PMID41841732
PMCPMC13055306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.